Bioventus Inc.
NASDAQ:BVS
9.58 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | Bioventus Inc. |
Symbool | BVS |
Munteenheid | USD |
Prijs | 9.58 |
Beurswaarde | 626,223,524 |
Dividendpercentage | 0% |
52-weken bereik | 3.9 - 14.38 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Anthony P. Bihl III |
Website | https://www.bioventus.com |
An error occurred while fetching data.
Over Bioventus Inc.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)